EVERSANA

On Rare Disease Day, EVERSANA remains committed to helping our pharmaceutical clients get much-needed therapies to patients. Together with colleagues like Mike Ryan, Joanna Derma and Drew McCormick, we continue to make a difference every day and work towards creating a healthier world. Learn more: https://lnkd.in/gi7RvyjV #RareDiseaseDay #EVERSANA #HealthcareInnovation

Today EVERSANA honors Rare Disease Day. From our CEO, Jim Lang and more than 7,000 team members, we stand with the rare disease community and will continue to do all that we can to create a healthier world for all. At EVERSANA, we are deeply rooted in our unwavering commitment to serve the rare disease community. Today and always, we proudly stand with patients and their families. #RareDiseaseDay #PatientMinded #WeAreEVERSANA

EVERSANA joins the more than 400 million patients around the world as we recognize Rare Disease Day, which begins now in our Asia Pacific region. Today, we honor the strength, resilience and courage of the rare disease community. Our teams from Singapore to St. Louis to Salerno, Italy will take a moment today to reflect on our vision – to create a healthier world for all – and work even harder to serve this community. #RareDiseaseDay #PatientMinded #WeAreEVERSANA

Discover how our comprehensive models and innovative solutions help overcome access barriers for rare disease patients at Access USA. Schedule a meeting today to explore our expertise in rare disease, ACTICS? eAccess, our Direct-to-Patient Care Model, and our affordability, copay and patient assistance programs: https://ow.ly/sBPa50UYPv6

Are you attending DIA’s Medical Affairs and Scientific Communications Forum poster? Explore EVERSANA’s latest research on AI in medical contact centers and literature surveillance for monitoring therapeutic areas, competitor landscapes and internal reporting. Learn more about EVERSANA’s Medical Information services by scheduling a meeting with our experts: https://ow.ly/4AKI50UYPRr Carolyn Quon, Michael DeLuca, PharmD, MBA, MSRA, Mary M., Dr. Varun Pandey, PhD, Natalia Sánchez Gandarillas

Meet EVERSANA at #BIO2024 to discuss a potential #commercialisation partnership. Our financially driven commercialization partnerships are an alternative to out-licensing.?Schedule a meeting with our team to discuss this alternative commercialization strategy for your assets.?? Let’s connect at BIO in Milan from March 17-19 in Milan to discuss how we can work together: https://ow.ly/MZuY50V1z42 #Partnerships #Commercialization #BIOEuropeSpring

Join EVERSANA at the World EPA Congress, March 5-6, 2025, in Amsterdam. On March 5th at 12:05pm in the Market Access Track, Pamela V., V.P. of HEOR, Value & Evidence for EVERSANA, will present an important session on “Securing Launch Success in Europe and the Role of Data and the JCA”. We look forward to seeing you in Amsterdam! LEARN MORE: https://ow.ly/W1Ok50UOOo7

Pharmaceutical manufacturers face numerous challenges in achieving optimal revenue. In our latest blog, Farah Ahmad and Faruk Abdullah explore the critical factors for success and the importance of early commercial strategy. Learn how a holistic approach and partnering with a dedicated commercialization expert can transform challenges into opportunities. Read the full article: https://ow.ly/23C550UMPky #Pharma #RevenueOptimization #Commercialization #DrugLaunch #COMPLETECommercialization

EVERSANA is proud to be a platinum sponsor of Pharma USA 2025! Join us March 18-19 in Philadelphia to connect with industry leaders, explore cutting-edge solutions, and shape the future of healthcare. Don’t miss this opportunity to be part of conversations driving real change! #PharmaUSA #HealthcareInnovation Learn more here: https://ow.ly/stQN50V2Uar

Experts across our #MedicalAffairs practice will be on-site at MAPS Americas 2025, ready for another great show. What are you most excited to learn about? Stop by booth 510 to discuss how our end-to-end, global Medical Affairs offerings are disrupting the industry and provide a new model that redefines scientific exchange and drives improved care pathways and optimizes patient outcomes. Take a sneak peek at our latest AI-enabled technologies, such as MI chatbots and our recently introduced Medical & Regulatory Accelerator tools. https://ow.ly/MXnh50V4bpW #MAPSAmericas #HealthcareInnovation #MedicalAffairs